| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artivion, Inc. (AORT) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. AORT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 831.9K | $30.00M | - | |
| Other | 193.8K | $6.99M | - | |
| VP | 156.1K | $5.63M | - | |
| Dir | 150.1K | $5.41M | - | |
| Dir | 149.9K | $5.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2020 | McCall Ronald D | Director | Sell | 4,734 | $26.05 | $123,339.64 | -3.6% | |
| Jan 21, 2020 | Holloway Jean F | VP, General Counsel | Sale+OE | 8,458 | $30.00 | $253,744.23 | -12.6% | |
| Jan 16, 2020 | Holloway Jean F | VP, General Counsel | Sale+OE | 195 | $30.00 | $5,850.00 | -0.3% | |
| Dec 12, 2019 | Holloway Jean F | VP, General Counsel | Sale+OE | 3,000 | $26.00 | $78,000.00 | -4.8% | |
| Nov 26, 2019 | Capps Scott B | VP, Clinical Research | Sale+OE | 7,184 | $24.93 | $179,107.90 | -4.8% | |
| Nov 19, 2019 | McCall Ronald D | Director | Sell | 4,000 | $24.64 | $98,564.80 | -2.9% | |
| Nov 13, 2019 | MacKin James P | President &CEO | Buy | 5,000 | $23.47 | $117,355.00 | +2.3% | |
| May 31, 2019 | Capps Scott B | VP, Clinical Research | Sell | 2,000 | $28.55 | $57,100.00 | -1.4% | |
| May 24, 2019 | McCall Ronald D | Director | Sell | 1,563 | $28.47 | $44,498.61 | -1.1% | |
| May 23, 2019 | McCall Ronald D | Director | Sell | 3,700 | $28.74 | $106,345.90 | -1.3% |